Clarithromycin Versus Metronidazole in First-Line

Helicobacter pylori clarithromycin eradication therapy metronidazole resistant triple therapy

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
17 Feb 2020
Historique:
received: 28 01 2020
revised: 09 02 2020
accepted: 12 02 2020
entrez: 22 2 2020
pubmed: 23 2 2020
medline: 23 2 2020
Statut: epublish

Résumé

International treatment guidelines for Randomized control trials (RCTs) comparing eradication rates between PAC and PAM first-line treatment up to December 2018 were included. We divided RCTs into four groups based on resistance to CAM (< 15% or ≥ 15%) and MNZ (< 15% or ≥ 15%). A total of 27 studies (4825 patients) were included. Overall eradication rates between PAC and PAM were similar (74.8% and 72.5%, relative risk (RR): 1.13, 95% confidence interval (CI): 0.91-1.39, Overall eradication rates with PAC and PAM were equivalent worldwide. In low MNZ-resistance areas, PAM may be recommended as first-line therapy. However, the efficacy of PAC may be insufficient, irrespective of susceptibility to CAM.

Sections du résumé

BACKGROUND BACKGROUND
International treatment guidelines for
METHODS METHODS
Randomized control trials (RCTs) comparing eradication rates between PAC and PAM first-line treatment up to December 2018 were included. We divided RCTs into four groups based on resistance to CAM (< 15% or ≥ 15%) and MNZ (< 15% or ≥ 15%).
RESULTS RESULTS
A total of 27 studies (4825 patients) were included. Overall eradication rates between PAC and PAM were similar (74.8% and 72.5%, relative risk (RR): 1.13, 95% confidence interval (CI): 0.91-1.39,
CONCLUSIONS CONCLUSIONS
Overall eradication rates with PAC and PAM were equivalent worldwide. In low MNZ-resistance areas, PAM may be recommended as first-line therapy. However, the efficacy of PAC may be insufficient, irrespective of susceptibility to CAM.

Identifiants

pubmed: 32079208
pii: jcm9020543
doi: 10.3390/jcm9020543
pmc: PMC7073899
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Can J Gastroenterol. 2013 Dec;27(12):701-6
pubmed: 24340314
Gut. 1997 Dec;41(6):735-9
pubmed: 9462204
J Formos Med Assoc. 2000 Sep;99(9):704-9
pubmed: 11000734
Aliment Pharmacol Ther. 2016 Feb;43(4):514-33
pubmed: 26694080
Gut. 2016 Sep;65(9):1439-46
pubmed: 26935876
J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S171-4
pubmed: 19120893
J Natl Cancer Inst. 1959 Apr;22(4):719-48
pubmed: 13655060
Clin Res Hepatol Gastroenterol. 2013 Sep;37(4):416-21
pubmed: 23168228
Am J Gastroenterol. 1998 Oct;93(10):1909-13
pubmed: 9772054
Pharmacogenetics. 2001 Jun;11(4):341-8
pubmed: 11434512
Gastroenterology. 2013 Jul;145(1):121-128.e1
pubmed: 23562754
Aliment Pharmacol Ther. 2017 Jul;46(2):106-114
pubmed: 28497487
Curr Pharm Des. 2014;20(28):4489-500
pubmed: 24180402
Am J Gastroenterol. 2005 May;100(5):1037-42
pubmed: 15842576
Clin Ther. 1999 Sep;21(9):1539-48
pubmed: 10509849
Gastroenterology. 2016 Jul;151(1):51-69.e14
pubmed: 27102658
Contemp Clin Trials. 2015 Nov;45(Pt A):139-45
pubmed: 26343745
Ann Clin Microbiol Antimicrob. 2010 Aug 13;9:22
pubmed: 20707901
Helicobacter. 2007 Aug;12(4):317-23
pubmed: 17669104
Gastroenterology. 2018 Nov;155(5):1372-1382.e17
pubmed: 29990487
Gut. 2010 Aug;59(8):1143-53
pubmed: 20525969
Braz J Microbiol. 2011 Apr;42(2):442-7
pubmed: 24031652
Med J Aust. 1989 Oct 16;151(8):431-5
pubmed: 2687668
Pharm World Sci. 2006 Aug;28(4):207-14
pubmed: 17066247
J Clin Gastroenterol. 2015 Jul;49(6):468-71
pubmed: 24921211
Gut. 1995 Jul;37(1):39-43
pubmed: 7672677
Clin Microbiol Infect. 2013 Apr;19(4):379-83
pubmed: 22512623
Aliment Pharmacol Ther. 2005 Mar 15;21(6):773-82
pubmed: 15771764
Lancet. 1994 Jun 11;343(8911):1503
pubmed: 7911202
Helicobacter. 2014 Aug;19(4):312-8
pubmed: 24690010
Clin Gastroenterol Hepatol. 2014 Feb;12(2):177-86.e3; Discussion e12-3
pubmed: 23751282
Aliment Pharmacol Ther. 2015 Apr;41(7):636-48
pubmed: 25707624
Expert Rev Anti Infect Ther. 2016 Jun;14(6):577-85
pubmed: 27077447
Tunis Med. 2012 Jan;90(1):31-5
pubmed: 22311445
Helicobacter. 2018 Aug;23(4):e12495
pubmed: 29873436
Expert Opin Investig Drugs. 2005 Apr;14(4):411-21
pubmed: 15882117
Aliment Pharmacol Ther. 2016 May;43(10):1048-59
pubmed: 26991399
Aliment Pharmacol Ther. 1998 Aug;12(8):741-5
pubmed: 9726387
Stat Med. 1989 Feb;8(2):141-51
pubmed: 2704896
Am J Gastroenterol. 2010 Jan;105(1):65-73
pubmed: 19755966
Lancet. 2016 Nov 12;388(10058):2355-2365
pubmed: 27769562
J Am Acad Dermatol. 1996 Apr;34(4):685-6
pubmed: 8601663
Aliment Pharmacol Ther. 2003 May 1;17(9):1125-35
pubmed: 12752349
Aliment Pharmacol Ther. 1997 Dec;11(6):1131-6
pubmed: 9663841
Aliment Pharmacol Ther. 2002 Nov;16(11):1933-8
pubmed: 12390102
World J Gastroenterol. 2005 Apr 28;11(16):2477-81
pubmed: 15832421
Ann Intern Med. 1999 Nov 2;131(9):668-72
pubmed: 10577329
Gut. 2007 Nov;56(11):1502
pubmed: 17938430
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Jun;97(6):714-7
pubmed: 15184853
Can J Gastroenterol Hepatol. 2017;2017:4385161
pubmed: 28349044
Digestion. 2015;92(2):55-9
pubmed: 26183105
Microb Drug Resist. 2017 Sep;23(6):727-732
pubmed: 27996373
Gut. 2017 Jan;66(1):6-30
pubmed: 27707777
World J Gastroenterol. 2015 Jan 7;21(1):351-9
pubmed: 25574111
J Gastroenterol Hepatol. 1999 May;14(5):468-75
pubmed: 10355512
Gastroenterol Clin North Am. 2015 Sep;44(3):577-96
pubmed: 26314669
J Gastroenterol Hepatol. 2007 Jul;22(7):1057-63
pubmed: 17608851
Aliment Pharmacol Ther. 1999 May;13(5):643-9
pubmed: 10233188
J Clin Neurosci. 2004 Aug;11(6):600-2
pubmed: 15261228
Front Microbiol. 2018 Dec 18;9:3154
pubmed: 30619218
Digestion. 2013;88(1):33-45
pubmed: 23880479
Pharmacotherapy. 2011 Mar;31(3):227-38
pubmed: 21361732
Dtsch Med Wochenschr. 1996 Jan 5;121(1-2):3-7; discussion 7-8
pubmed: 8565802
Helicobacter. 1996 Sep;1(3):138-44
pubmed: 9398894
Helicobacter. 2009 Feb;14(1):29-35
pubmed: 19191893
Helicobacter. 1997 Jun;2(2):92-7
pubmed: 9432335
Aliment Pharmacol Ther. 2007 Aug 1;26(3):343-57
pubmed: 17635369
Adv Med Sci. 2008;53(2):310-5
pubmed: 18952538
J Clin Microbiol. 2007 Dec;45(12):4006-10
pubmed: 17942652
Clin Toxicol. 1981 Nov;18(11):1277-83
pubmed: 7341053
Am J Gastroenterol. 2018 Oct;113(10):1444-1457
pubmed: 30171216
Gastroenterol Clin North Am. 2015 Sep;44(3):537-63
pubmed: 26314667
Aliment Pharmacol Ther. 2003 May 1;17(9):1137-43
pubmed: 12752350
Helicobacter. 2018 Apr;23(2):e12456
pubmed: 29271026
Aliment Pharmacol Ther. 1999 May;13(5):667-73
pubmed: 10233191
Intern Med. 2006;45(6):405-9
pubmed: 16617193
Oncology. 2017;93 Suppl 1:15-19
pubmed: 29258111
J Gastroenterol Hepatol. 2004 Jun;19(6):619-25
pubmed: 15151614
Helicobacter. 2001 Sep;6(3):254-61
pubmed: 11683930
J Infect Chemother. 2018 Jul;24(7):538-543
pubmed: 29605555

Auteurs

Masaki Murata (M)

Department of Gastroenterology, Shiga University of Medical Science Hospital, Otsu, Shiga 520-2192, Japan.
Department of Gastroenterology, National Hospital Organization Kyoto Medical Center, Fushimi, Kyoto 612-8555, Japan.

Mitsushige Sugimoto (M)

Division of Digestive Endoscopy, Shiga University of Medical Science Hospital, Otsu, Shiga 520-2192, Japan.
Department of Gastroenterological Endoscopy, Tokyo Medical University Hospital, Shinjuku, Tokyo 160-0023, Japan.

Hitomi Mizuno (H)

Toyoda Aoba Clinic, Iwata, Shizuoka 438-0821, Japan.

Takeshi Kanno (T)

Division of Gastroenterology, Tohoku University Hospital, Sendai, Miyagi 980-8578, Japan.

Kiichi Satoh (K)

Department of Gastroenterology, International University of Health and Welfare Hospital, Nasushiobara, Tochigi 329-2763, Japan.

Classifications MeSH